DUBLIN--(BUSINESS WIRE)--The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has been added to ResearchAndMarkets.com's offering.
The U.S. medical diagnostics market is anticipated to reach US$40.10 billion in 2026, witnessing growth at a CAGR of 4.63%, over the period 2022-2026.
The factors such as increasing geriatric population, growing burden of chronic diseases, escalating penetration of electronic health record (EHR) systems, hike in healthcare expenditure and expanding urbanization would drive the growth of the market.
However, the market growth would be challenged by the dearth of trained laboratory technicians, the high cost of high-end molecular diagnostics and in vitro diagnostics devices and challenging premarket approval (PMA) & IVD labelling requirements.
A few notable trends include surging adoption of healthcare-related devices like wearables, the emergence of various pandemic diseases, rising integration with Artificial Intelligence and growing awareness for personalized medicine.
The U.S. medical diagnostics market has been segmented on the basis of type, product type and end-users. In terms of type, the market can be bifurcated into in-vitro diagnostics and in-vivo diagnostics. The U.S. in-vitro diagnostics market is further divided on the basis of product type and application.
Depending on the product type, the U.S. medical diagnostics market can be segmented into reagents, instruments and software & services. Whereas, the market can be split into hospitals, diagnostic centers and Physician Office Labs (POLs) & others, on the basis of end-users.
The fastest-growing regional market was Southern U.S., owing to the rising susceptibility of the population to various chronic and infectious diseases, growing adoption of automation in reference laboratories and hospitals, increasing patient awareness about personalized medicine and shifting preference towards point-of-care (POC) testing.
Scope of the report
- The report provides a comprehensive analysis of the U.S. medical diagnostics market segmented on the basis of type, product type, end-users and region.
- The major regional and country markets (Southern, Mid-Western, Western and North Eastern U.S.) have been analyzed.
- The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
- The competitive landscape of the market, along with the company profiles of leading players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, Quest Diagnostics Inc., and BioMerieux SA) are also presented in detail.
Key Target Audience
- Diagnostic Service Providers
- Diagnostic Products Manufacturers and Distributors of IVD Products
- Hospitals, Public Labs, Diagnostic Centers and Other Stakeholders
- Organizations, Forums and Alliances related to Medical Diagnostics
- Government Bodies & Regulating Authorities
Key Topics Covered:
1. Market Overview
1.1 Introduction
1.2 Types of Diagnostics
1.3 General Components of a Diagnostic Procedure
1.4 Anatomy of a Diagnostic Test
1.5 Categories of Diagnostic Tests
1.6 Major Roles of Diagnostic Testing
1.7 Sources of Medical Information for Diagnosis
1.8 Common Types of Diagnostic Tools
2. Impact of COVID-19
2.1 Demand Surge for Medical Diagnostics
2.2 Growth in Government Spending on Healthcare
2.3 Surging Adoption of Diagnostics Based on Reverse-Transcription Polymerase Chain Reaction (RT-PCR)
3. Global Market Analysis
3.1 The U.S. Medical Diagnostics Market by Value
3.2 The U.S. Medical Diagnostics Market Forecast by Value
3.3 The U.S. Medical Diagnostics Market by Type
3.3.1 The U.S. In-Vitro Diagnostics Market by Value
3.3.2 The U.S. In-Vitro Diagnostics Market Forecast by Value
3.3.3 The U.S. In-Vitro Diagnostics Market by Product Type
3.3.4 The U.S. In-Vitro Diagnostics Product Type Market by Value
3.3.5 The U.S. In-Vitro Diagnostics Product Type Market Forecast by Value
3.3.6 The U.S. In-Vitro Diagnostics Market by Application
3.3.7 The U.S. In-Vitro Diagnostics Application Market Forecast by Value
3.3.8 The U.S. In-Vivo Diagnostics Market by Value
3.3.9 The U.S. In-Vivo Diagnostics Market Forecast by Value
3.4 The U.S. Medical Diagnostics Market by Product Type
3.4.1 The U.S. Medical Diagnostics Product Type Market by Value
3.4.2 The U.S. Medical Diagnostics Product Type Market Forecast by Value
3.5 The U.S. Medical Diagnostics Market by End-Users
3.5.1 The U.S. Medical Diagnostics End-User Market by Value
3.5.2 The U.S. Medical Diagnostics End-User Market Forecast by Value
3.6 The U.S. Medical Diagnostics Market by Region
4. Regional Market
4.1 Southern U.S.
4.1.1 Southern U.S. Medical Diagnostics Market Forecast by Value
4.2 Mid-Western U.S.
4.3 Western U.S.
4.4 North Eastern U.S.
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increasing Geriatric Population
5.1.2 Growing Burden of Chronic Diseases
5.1.3 Escalating Penetration of Electronic Health Record (EHR) Systems
5.1.4 Hike in Healthcare Expenditure
5.1.5 Expanding Urbanization
5.2 Key Trends and Developments
5.2.1 Surging Adoption of Healthcare-related Devices Like Wearables
5.2.2 Emergence of Various Pandemic Diseases
5.2.3 Rising Integration with Artificial Intelligence
5.2.4 Growing Awareness on Personalized Medicine
5.3 Challenges
5.3.1 Dearth of Trained Laboratory Technicians
5.3.2 High Cost of High-end Molecular Diagnostics & In-Vitro Diagnostics Devices
5.3.3 Challenging Premarket Approval (PMA) & IVD Labelling Requirements
6. Competitive Landscape
6.1 The U.S. Market
6.1.1 Revenue Comparison of Key Players
6.1.2 Market Capitalization Comparison of Key Players
6.1.3 R&D Comparison of Key Players
7. Company Profiles
7.1 Business Overview
7.2 Financial Overview
7.3 Business Strategies
- Roche Holding AG
- Abbott Laboratories
- Danaher Corporation
- Becton, Dickinson and Company
- Quest Diagnostics Inc.
- BioMerieux SA
For more information about this report visit https://www.researchandmarkets.com/r/71jrpt
